An antigenic peptide produced by reverse splicing and double asparagine deamidation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 29, 2011, Pages

  Dalet, Alexandre ^a   Robbins, Paul F ^b   Stroobant, Vincent ^a   Vigneron, Nathalie ^a   Li, Yong F ^b   El Gamil, Mona ^b   Hanada, Ken Ichi ^b   Yang, James C ^b   Rosenberg, Steven A ^b   Van Den Eyndea, Benoit̂ J ^a  

^a DE DUVE INSTITUTE   (Belgium)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Antigen processing; Peptide splicing; Tumor antigen

Indexed keywords

ASPARAGINE; ASPARTIC ACID; CARRIER PROTEIN; GLYCOPEPTIDASE; HLA A24 ANTIGEN; MONOPHENOL MONOOXYGENASE; PROTEASOME; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ANTIGENICITY; ARTICLE; CELL ISOLATION; CELL STRUCTURE; CELL SURFACE; CONTROLLED STUDY; CYTOSOL; DEAMINATION; DEGLYCOSYLATION; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN TRANSPORT; TUMOR ASSOCIATED LEUKOCYTE;

ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; CHEMICAL FRACTIONATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENDOPLASMIC RETICULUM; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA; MONOPHENOL MONOOXYGENASE; PEPTIDES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT;

EID: 79961091168     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1101892108     Document Type: Article

References (55)

1. Heidecker L, et al. (2000) Cytolytic T lymphocytes raised against a human bladder carcinoma recognize an antigen encoded by gene MAGE-A12. J Immunol 164:6041-6045. (Pubitemid 30389854)
2. Ma W, et al. (2004) Two new tumor-specific antigenic peptides encoded by gene MAGE-C2 and presented to cytolytic T lymphocytes by HLA-A2. Int J Cancer 109:698-702. (Pubitemid 38405616)
3. van der Bruggen P, et al. (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643-1647.
4. Gaugler B, et al. (1994) Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 179:921-930. (Pubitemid 24065650)
5. Bakker ABH, et al. (1994) Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J Exp Med 179:1005-1009.
6. Brichard V, et al. (1993) The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 178:489-495. (Pubitemid 23218197)
7. Kawakami Y, et al. (1994) Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA 91:3515-3519. (Pubitemid 24139460)
8. Coulie PG, et al. (1994) A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 180:35-42. (Pubitemid 24181053)
9. Rock KL, et al. (1994) Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761-771. (Pubitemid 24294452)
10. Bacik I, et al. (1997) Introduction of a glycosylation site into a secreted protein provides evidence for an alternative antigen processing pathway: Transport of precursors of major histocompatibility complex class I-restricted peptides from the endoplasmic reticulum to the cytosol. J Exp Med 186:479-487. (Pubitemid 27360792)
11. Mosse CA, et al. (1998) The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol. J Exp Med 187:37-48. (Pubitemid 28044818)
12. Coulie PG, et al. (1995) A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc Natl Acad Sci USA 92:7976-7980.
13. Guilloux Y, et al. (1996) A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucos-aminyltransferase V gene. J Exp Med 183:1173-1183. (Pubitemid 26113980)
14. Robbins PF, et al. (1997) The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes. J Immunol 159:303-308. (Pubitemid 127493713)
15. Van den Eynde BJ, et al. (1999) A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription. J Exp Med 190:1793-1800.
16. Probst-Kepper M, et al. (2001) An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor-infiltrating CD8 T lymphocytes. J Exp Med 193:1189-1198. (Pubitemid 32488371)
17. Wang R-F, Appella E, Kawakami Y, Kang X, Rosenberg SA (1996) Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes. J Exp Med 184:2207-2216. (Pubitemid 27023721)
18. Malarkannan S, Horng T, Shih PP, Schwab S, Shastri N (1999) Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanism. Immunity 10:681-690. (Pubitemid 29302921)
19. Ronsin C, et al. (1999) A non-AUG-defined alternative open reading frame of the intestinal carboxyl esterase mRNA generates an epitope recognized by renal cell carcinoma-reactive tumor-infiltrating lymphocytes in situ. J Immunol 163:483-490. (Pubitemid 29295877)
20. Ferris RL, et al. (1999) Processing of HIV-1 envelope glycoprotein for class I-restricted recognition: Dependence on TAP1/2 and mechanisms for cytosolic localization. J Immunol 162:1324-1332. (Pubitemid 29307002)
21. Selby M, et al. (1999) Hepatitis C virus envelope glycoprotein E1 originates in the endoplasmic reticulum and requires cytoplasmic processing for presentation by class I MHC molecules. J Immunol 162:669-676. (Pubitemid 29035385)
22. Skipper JCA, et al. (1996) An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. J Exp Med 183:527-534. (Pubitemid 26059516)
23. Zarling AL, et al. (2000) Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo. J Exp Med 192:1755-1762. (Pubitemid 32049768)
24. Zarling AL, et al. (2006) Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy. Proc Natl Acad Sci USA 103:14889-14894. (Pubitemid 44527824)
25. Hanada K, Yewdell JW, Yang JC (2004) Immune recognition of a human renal cancer antigen through post-translational protein splicing. Nature 427:252-256. (Pubitemid 38112041)
26. Vigneron N, et al. (2004) An antigenic peptide produced by peptide splicing in the proteasome. Science 304:587-590. (Pubitemid 38541917)
27. Warren EH, et al. (2006) An antigen produced by splicing of noncontiguous peptides in the reverse order. Science 313:1444-1447. (Pubitemid 44360274)
28. Altrich-VanLith ML, et al. (2006) Processing of a class I-restricted epitope from tyrosinase requires peptide N-glycanase and the cooperative action of endoplasmic reticulum aminopeptidase 1 and cytosolic proteases. J Immunol 177:5440-5450. (Pubitemid 44527617)
29. Dalet A, Vigneron N, Stroobant V, Hanada K, Van den Eynde BJ (2010) Splicing of distant peptide fragments occurs in the proteasome by transpeptidation and produces the spliced antigenic peptide derived from fibroblast growth factor-5. J Immunol 184:3016-3024.
30. Robbins PF, et al. (1994) Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res 54:3124-3126. (Pubitemid 24208914)
31. Kang X, et al. (1995) Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor-infiltrating lymphocytes. J Immunol 155:1343-1348.
32. Kubo RT, et al. (1994) Definition of specific peptide motifs for four major HLA-A alleles. J Immunol 152:3913-3924. (Pubitemid 24111063)
33. Maier R, et al. (1994) Peptide motifs of HLA-A3, -A24, and -B7 molecules as determined by pool sequencing. Immunogenetics 40:306-308. (Pubitemid 24275666)
34. Wölfel T, et al. (1994) Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur J Immunol 24:759-764. (Pubitemid 24076646)
35. Wölfel C, et al. (2000) Transporter (TAP)- and proteasome- independent presentation of a melanoma-associated tyrosinase epitope. Int J Cancer 88:432-438.
36. Akiyama K, et al. (1994) Replacement of proteasome subunits X and Y by LMP7 and LMP2 induced by interferon-gamma for acquirement of the functional diversity responsible for antigen processing. FEBS Lett 343:85-88.
37. Groettrup M, et al. (1996) A third interferon-gamma-induced subunit exchange in the proteasome. Eur J Immunol 26:863-869.
38. Chapiro J, et al. (2006) Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation. J Immunol 176:1053-1061. (Pubitemid 43099706)
39. Dalet A, Stroobant V, Vigneron N, Van den Eynde BJ (2011) Differences in the production of spliced antigenic peptides by the standard proteasome and the immunoproteasome. Eur J Immunol 41:39-46.
40. Misaghi S, Pacold ME, Blom D, Ploegh HL, Korbel GA (2004) Using a small molecule inhibitor of peptide: N-glycanase to probe its role in glycoprotein turnover. Chem Biol 11:1677-1687. (Pubitemid 39651302)
41. York IA, et al. (1994) A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell 77:525-535.
42. Jimbow K, et al. (2000) Assembly, target-signaling and intracellular transport of tyrosinase gene family proteins in the initial stage of melanosome biogenesis. Pigment Cell Res 13:222-229. (Pubitemid 30610798)
43. Halaban R, et al. (2002) Abnormal acidification of melanoma cells induces tyrosinase retention in the early secretory pathway. J Biol Chem 277:14821-14828. (Pubitemid 34952554)
44. Popescu CI, Paduraru C, Dwek RA, Petrescu SM (2005) Soluble tyrosinase is an endoplasmic reticulum (ER)-associated degradation substrate retained in the ER by calreticulin and BiP/GRP78 and not calnexin. J Biol Chem 280:13833-13840. (Pubitemid 40517281)
45. Svedine S, Wang T, Halaban R, Hebert DN (2004) Carbohydrates act as sorting determinants in ER-associated degradation of tyrosinase. J Cell Sci 117:2937-2949. (Pubitemid 39117669)
46. Wang N, Daniels R, Hebert DN (2005) The cotranslational maturation of the type I membrane glycoprotein tyrosinase: The heat shock protein 70 system hands off to the lectin-based chaperone system. Mol Biol Cell 16:3740-3752. (Pubitemid 41077083)
47. Ostankovitch M, Altrich-Vanlith M, Robila V, Engelhard VH (2009) N-glycosylation enhances presentation of a MHC class I-restricted epitope from tyrosinase. J Immunol 182:4830-4835.
48. Manneberg M, Lahm HW, Fountoulakis M (1995) Oxidation of cysteine and methionine residues during acid hydrolysis of proteins in the presence of sodium azide. Anal Biochem 224:122-127.
49. Angel PM, Orlando R (2006) Trypsin is the primary mechanism by which the (18)O isotopic label is lost in quantitative proteomic studies. Anal Biochem 359:26-34. (Pubitemid 44693522)
50. Schnölzer M, Jedrzejewski P, Lehmann WD (1996) Protease-catalyzed incorporation of 18O into peptide fragments and its application for protein sequencing by electrospray and matrix-assisted laser desorption/ionization mass spectrometry. Electrophoresis 17:945-953.
51. Liepe J, et al. (2010) The 20S proteasome splicing activity discovered by SpliceMet. PLoS Comput Biol 6:e1000830.
52. Gillon AD, et al. (2008) Biosynthesis of circular proteins in plants. Plant J 53:505-515. (Pubitemid 351172020)
53. Min W, Jones DH (1994) In vitro splicing of concanavalin A is catalyzed by asparaginyl endopeptidase. Nat Struct Biol 1:502-504.
54. Watts C, et al. (2003) Creation versus destruction of T cell epitopes in the class II MHC pathway. Ann N Y Acad Sci 987:9-14. (Pubitemid 36584002)
55. Lagerwerf FM, van de Weert M, Heerma W, Haverkamp J (1996) Identification of oxidized methionine in peptides. Rapid Commun Mass Spectrom 10:1905-1910. (Pubitemid 27059008)